老年人循环蛋白质的长期时间稳定性
Hulda K Ingvarsdottir1, Heida Bjarnadottir1,2, Elisabet A Frick1,2
1Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
循环蛋白质在五年内的稳定性有很大差异. 遗传因素和疾病阶段显著影响蛋白质稳定性,对生物标志物发展至关重要.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 衰老研究研究 衰老研究
- 生物标志物发现发现
背景情况:
- 循环蛋白质提供了对健康和衰老的见解.
- 影响蛋白质组长期稳定的因素在很大程度上是未知的.
- 了解蛋白质稳定性是生物标志物开发的关键.
研究的目的:
- 评估成千上万的循环蛋白质的五年时间稳定性.
- 确定有助于血清蛋白质组长期稳定性的因素.
主要方法:
- 采用了SomaScan蛋白质组学技术.
- 分析了AGES-雷克雅未克研究中3,093名参与者的血清样本 (平均年龄76岁).
- 在五年时间内评估了7,288种蛋白质的时间稳定性.
主要成果:
- 观察到蛋白质时间稳定性的显著变化.
- 暂时稳定的蛋白质通常是细胞外和与疾病相关的.
- 时间变化的蛋白质经常参与细胞内清洁功能.
- 蛋白质稳定性与组织转录基因稳定性没有相关性.
- 遗传效应和疾病阶段被确定为对蛋白质稳定性的主要贡献者.
结论:
- 循环蛋白质的稳定性是特定于蛋白质的,并受到遗传和生物因素的影响.
- 这些发现对于推进生物标志物开发和精准医学至关重要.
- 循环蛋白质的时间稳定性与转录基因稳定性不同.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
217
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
223
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
Factors Affecting Protein-Drug Binding: Patient-Related Factors
291
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
291
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K


